ArticleFrontiers in immunology2022

Chronic CD40L blockade is required for long-term cardiac allograft survival with a clinically relevant CTLA4-Ig dosing regimen.

Lukas W Unger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.